TRAMITZ

This brand name is authorized in Nigeria.

Active ingredients

The drug TRAMITZ contains one active pharmaceutical ingredient (API):

1	Telmisartan UNII U5SYW473RQ - TELMISARTAN
	Telmisartan is an orally active and specific angiotensin II receptor (type AT1) antagonist. Telmisartan selectively binds the AT1 receptor. The binding is long-lasting.
	Read more about Telmisartan

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-7289	Tablet	TRAMITZ TABLETS (TELMISARTAN USP 40mg). TAB 40 mg 3x10	70 RNW-PP-336294 TRAMITZ TABLETS (TELMISARTAN USP 40mg). TELMISARTAN Telmisartan 40mg, Sodium hydroxide Meglumine Povidone K25 Lactose monohydrate Povidone Crospovidone Lactose anhydrous Magnesium stearate B4-7289 CARDIOVASCULAR SYSTEM Imported Products 310 Prescription Only Medicine (POM) 6/1/2023 LEOTETRA HEALTHCARE LTD, GIDA NA'ADADE NAIBAWA KANO KANO 8066471561 leotetranigltd@outlook.com INNOVA CAPTAB PVT. LTD, 81-B, EPIP PHASE – 1 JHARMAJRI, BADDI (H.P) PIN – 173205 INDIA. , India	31/01/2024

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C09CA07	Telmisartan	C Cardiovascular system → C09 Agents acting on the renin-angiotensin system → C09C Angiotensin II antagonists, plain → C09CA Angiotensin II antagonists, plain
Discover more medicines within C09CA07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-7289